Correlation Between Tarsus Pharmaceuticals and Safe
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Safe at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Safe into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Safe and Green, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Safe and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Safe. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Safe.
Diversification Opportunities for Tarsus Pharmaceuticals and Safe
-0.82 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tarsus and Safe is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Safe and Green in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Safe and Green and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Safe. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Safe and Green has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Safe go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Safe
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.34 times more return on investment than Safe. However, Tarsus Pharmaceuticals is 2.94 times less risky than Safe. It trades about 0.25 of its potential returns per unit of risk. Safe and Green is currently generating about -0.2 per unit of risk. If you would invest 3,900 in Tarsus Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 758.00 from holding Tarsus Pharmaceuticals or generate 19.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 95.65% |
Values | Daily Returns |
Tarsus Pharmaceuticals vs. Safe and Green
Performance |
Timeline |
Tarsus Pharmaceuticals |
Safe and Green |
Tarsus Pharmaceuticals and Safe Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tarsus Pharmaceuticals and Safe
The main advantage of trading using opposite Tarsus Pharmaceuticals and Safe positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Safe can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Safe will offset losses from the drop in Safe's long position.Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Equity Valuation Check real value of public entities based on technical and fundamental data |